We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Midas Cap. | LSE:MDS | London | Ordinary Share | GB00B01WR582 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/11/2006 16:12 | I have just got back from the AGM. I'm not sure why the announcement had to be so short, but it was not bad news. The last trading update was about six weeks ago and there is now about six weeks left to trade in the current financial year. It was most encouraging that we are still in line with expectations and the trends mentioned in September (i.e. improved prospects and shortened sales cycles) have continued. There was a discussion at the meeting and it is clear that not only do the directors have confidence in strong organic growth, but also the focus of activity is directed towards achieving it. I talked to all directors except Bernard Fairman who was not there. They are confident. I get the impression that although the forecast is not yet "in the bag" it will be achieved without any large new name business. Having said that there are clearly good prospects of landing new business this year. I met Mark Robertson for the first time. He was impressive and I am confident that the Blue Curve business is doing very well indeed. CAPS prospects are stronger than ever, I still do believe that this market will provide significant business next year as well as this year. There is now a large amount of recurring support revenue. Add to that the "global rollouts" and it is easy to see that the 2007 earnings are already "visible". | mollymolly | |
07/11/2006 15:22 | Hi P2 Interesting announcement from Panmure Gordon stating they have formed a strategic partnership with GMP Securities of Canada to work together on equity capital market transactions for Canadian entities which wish to access UK markets. GMP will establish GMP Securities Europe LLP in London to work with Panmure Gordon. GMP is capitalised at 1.2 bil dollars. In view of Panmures recent glowing testomonial on Caps installation, perhaps there may be a significant opportunity to add them to Mondas growing prospect list. Almost fogot to mention due to the excitement of the agm announcement Regards P1 | spurious | |
07/11/2006 15:04 | P1 Not sure what to make of it as there was so little said. There have been a few occasions when I have felt we have not stepped up to the mark. Today is one of those mysteries. Why did they not fill the space? I hope we get an update on the AGM from other attendees. P2 | gac141 | |
07/11/2006 13:30 | Wonder how brief the statement would be if there was any bad news. Perhaps the statement would after long and careful deliberation read something like this Oh...sh.t !!!!! | spurious | |
07/11/2006 13:08 | Peter Waller was brought in to replace Colin Peters and the announcement said ' Mr Waller brings to Mondas a wealth of experience at a senior executive level from a 30-year career in the software and services sector' Experience should have told him that this was not acceptable. | viney1 | |
07/11/2006 13:04 | Hi Orange Perhaps we are missing the point. Obviously Mr Waller felt a little rushed after missing his connection!!!!!!! I felt that he was clearly highlighting a new West end pantomine...Trends.. that opened on the 26 September Has anyone heard from Mondas re the results of the agm because there appears to be a great story unfolding!!!!! Any thoughts George Regards SP | spurious | |
07/11/2006 12:34 | I was hoping for some interesting insight! Can they seriously think that this is acceptable!!! Amateur night! Or are a they trying to hide something? | canter | |
07/11/2006 12:16 | Nice to see they have the PR sorted..... Total rubbish. Perhaps Peter Waller will buy another 10,000 shares and think that will do the trick. Laughable. | will b | |
07/11/2006 12:00 | Not seen a more dismal attempt at Public Relations. Are the company serious? Peter Waller needs to get in touch with the market and shareholders if he thinks that will satisfy both. Clearly he has not spoken to nor understands either to produce that. Where in a few curt words is the confidence of the business? My 9-year-old son could have done a better job! SJW | steve_wilson | |
07/11/2006 11:36 | Talking of PR, that Peter Waller is not exactly a man of many words: "At the AGM of Mondas plc, to be held at 11.30am today, Peter Waller, Chairman, will make the following comment: "The Company continues to see the trends outlined in the announcement of 26 September, and since then trading remains in line with expectations." | orange1 | |
06/11/2006 12:37 | Quoted from Rambutan's post" MDS- which is the largest (world leading) supplier of tech-based solutions (stp)" What does the Celent report have to say about which supplier is the leading provider for corporate actions? I assume Rambutan means corporate actions when he quotes STP. This research company is independent and issued a report in 2004 and a follow up report in 2006 about the company's participating in this exciting field of corporate actions. I have not been able to find out much of what is written in the report, but it seems at odds with the quote above. I would be grateful if anyone could post what the report said about Mds. I think the report identifies Xercitec and Tata as the leading suppliers. I copy a quote from the 2006 report below: "Xcitek is a dominant, established provider based upon customer base to date but is facing fierce competition from multiple sources. SmartStream and CheckFree are challenging for technology leadership by focusing their efforts on automating systems across the entire transaction life cycle. TCS is long-time participant with some of the most difficult engagements in the space and a growing presence in the US." | magpie99 | |
06/11/2006 12:00 | Look at Gresham (GHT). They have been loss making for years and are only forecasting a small profit. P/e around 100. GHT have a leading product in an exciting market. | mollymolly | |
05/11/2006 21:15 | bit of sunday sillyness. in ic i saw this write up of clinphones (CNP) results, and as i skimmed through i thought of mondas - me in brackets... 80% of pharma cos (banks and brokers) still use paper-based systems when process drug development (corporate actions) data. Yet, with growing regulations and the need to process results faster (also, cut costs), that system is proving inefficient. So, CNP (MDS) - which is the largest (world leading) supplier of tech-based solutions (stp) for clinical trials (for corporate actions) - is growing fast on the back of that need to modernise. Sales grew strongly helped by a 6x (?x) increase in license rev from Clinical Total Management software (caps, blue curve and resource) - that product has now been installed at one of the UK's top 5 bios (global rollout of caps at a top 10 global bank and a global rollout of blue curve at a top 5 global bank). Also, CLN's voice recog product has now been installed at a top 10 pharma. (also resource has now been installed in a third of UK further education establishments and has a fruitfull relationship with Pearson) So, operations profit grew at 40% to £3m - turnover £20m, £1.8m pretax ie 2.5p eps. CLN is buying Datalabs for up to £69m. (no big acquisitions currently needed!) Investec upgraded eps forecast to 8.3p for 07 to reflect the above purchase. (T&G confident of eps of 1.84 for current yr and 2.5p+ for 07 - and some think these forecasts conservative) Mkt cap £137m at 215p, with £1.4m cash, pe 88. (mkt cap of £5.3m at 15p, with £2m? cash, 06 pe 8, 07 pe 5.9) hmmm. methinks that mds doesn't look too dissimilar from a true growth share such as cnp, but is valued as an about-to-go-bust share! | rambutan2 | |
05/11/2006 17:10 | I think that the above post was aimed at Minorplanet Systems (MPS)& not Mondas.I can forgive a slip of the finger. | cocker | |
04/11/2006 21:38 | Transense Technlgy Michelin launches TPMS RNS Number:4498L Transense Technologies PLC 03 November 2006 Transense Technologies plc ("Transense") Statement re agreement Michelin launches commercial vehicle Tyre Pressure Monitoring System "TPMS" After several years of intensive research & development Michelin, the world's largest tyre manufacturer, and Honeywell, one of the world's leading automotive technology suppliers, announced in the US yesterday the launch of the eTire II battery-less TPMS for commercial vehicles. The eTire II system is based on Transense's surface acoustic wave ("SAW") technology, which Michelin licensed in 2001 for in- and on-tyre applications... | amt | |
02/11/2006 17:04 | Something is up. 2 Days over 200k trades. Good news on the way? Pip Pip PT | palm top | |
02/11/2006 13:42 | Rambutan, I agree with you that the share price should be higher. When Mondas acquired Blue Curve, I thought it impossible that Blue Curve could achieve the maximum earnout. Now it looks likely. I for one am happy about this. Not only have we had a huge amount of profit from Blue Curve this year, surely the base is one from which even bigger things can be looked for in 2007. I agree that it would be disappointing to pay the earnout at 17.5p share price (the company has, I think, a cash option). However, I do feel confident that the share price will be very much higher when payment is due around March next year. You comment on the size of shareholdings of the directors. Of course most comparable companies have founder directors who hold much higher stakes. We got rid of our founder! We can only guess at the financial position of the directors. It would be silly however, to assume that they have loads of cash, but do not want to invest. I presume Mr Fairman is not allowed to invest as he represents Foresight. Colin Peters has 1.6M shares so has a keen interest, and Ian Selby bought some more just over a month ago. Magpie, I am sure that there is a solid level of support for the directors and although the share price is still low that does not mean that the company could be bought at anything like the current level. Most holders are long term holders who have invested in the hope and expectation that the Company's products will take off. We are very unlikely to agree to sell just when things are coming good. | mollymolly | |
02/11/2006 13:13 | The longer the share price weakness continues the more fearfull I am of a sell out, giving short term shareholders a fast profit and a thumping loss for long term shareholders. Bond International seems to be a company that got it right. The share price went from below 20 p to over £1 in a fairly short space, and they sell to the recruitment industry. I would have thought an industry with lesser profit potential than banking/finance. Perhaps we should invite over the directors of Bond International to show our board how its done? I certainly hope the above posts are being heard by the board, or maybe they only answer to Foresight with its now huge stake, and shareholder democracy is at the same level as when Tim Simon shared exec and Chairman roles | magpie99 | |
02/11/2006 10:44 | yes, they certainly seem to have hidden the buy note from any of their own clients - must rank as the least successfull buy note ever! the reality gap between where mds stand in the real world and where the share price stands is certainly at its greatest ever. in normal circumstances this would be slightly worrying and in need of proper investigation, but the serious problem now is that of the blue curve earnout. i for one will not be happy to have my stake diluted at the max earnout. it's the board's responsibility to protect shareholder value and ending up with a much larger earnout than needed is not doing that. it will reflect very poorly on everyone involved and, of course, be keenly noted by any potential investors who will no doubt be inclined to connect it with the v small percentage of shares that the board holds. | rambutan2 | |
02/11/2006 08:49 | T&G and directors must be doing something wrong. The strong position Mondas is in is not reflected in the share price. T&G say BUY and the price falls. Investors are not exactly hanging on their every word! It is time to change T&G or at least look for coverage from an analyst who can command some respect. | jw885 | |
02/11/2006 08:22 | Refer back to my previous point 20 Oct "What are T&G doing? Is it not their job to promote the business to their clients? A buy note at 25p.... all ingredients for a stable share price...Yet nothing of the sort. Directors need to grasp this thorny issue and deal with it or Mondas will continue with penny share mentality with huge volatility. There is a job to be done" Mondas and T&G go back some time maybe time for a mutual parting of the waves? Buy notes of 25p and being the lowest on the bid do not mix. No new interest in shares save a couple of buys since the end of September. What looks like a resounding success is undermined by other influences. | hug00 | |
01/11/2006 19:24 | T&G have always been average and they seem to have done nothing for Mondas in recent years. The board need to exercise their prerogative and change their nominated broker. | marcy | |
01/11/2006 16:09 | Rambutan I am totally bemused by all of today's action. Period! As for Teathers marking us down, I am rapidly loosing faith in them. George | gac141 | |
01/11/2006 12:50 | 100k buy at 15p = hooray 50k sell at 13p = boo | rambutan2 | |
01/11/2006 10:33 | Strong case for investment. Renewed attention today..... Speculation chatter raised..... Mondas on the Radar once again...... Cheers Andy | andy man |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions